Broadfin Capital, LLC and 2 Others Buys $895K of Biodelivery Sciences International Inc (BDSI) — SEC Form 4, Nov 09, 2021

Open-Market Net Purchase · SEC Form 4
+$894,566

Equity position changed by +5.5%

Reporting Owners
Director
TXN 2021-11-05 · FILED 2021-11-09
Equity Position 4.96M sh 4,700,689 → 4,958,489
Equity Change +5.5% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2021-11-09
Report Date
2021-11-05
Accession No.
0001103021-21-000110
Accepted At
2021-11-09 10:28 UTC
Reporting Owners
Name Relationship
Broadfin Capital, LLC CIK 0001511901
Director
Broadfin Healthcare Master Fund Ltd CIK 0001511900
Director
Kevin Kotler CIK 0001601692
Director
Broadfin Capital, LLC at Biodelivery Sciences International Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Biodelivery Sciences International Inc
2022-03-22 Gift/Other — View
2022-02-15 - — View
2022-01-31 Exercise — View
2021-11-22 Buy +$306,000 View
2021-11-15 Buy +$320,000 View
All filings by this insider at Biodelivery Sciences International Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2021-11-05 P - Purchase 257,800 A $3.47 +$894,566 4,958,489 Indirect
Footnotes (2)
F1
There are 4,400,689 shares of Common Stock held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Kevin Kotler affirmatively (i) disclaims beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of his pecuniary interest therein, and (iii) disclaims being a "group" for purposes of Section 16. Show more
F2
557,800 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC. Show more
Other insiders at Biodelivery Sciences International Inc
All Biodelivery Sciences International Inc insider activity
GET /v1/forms/4/0001103021-21-000110 API docs
View Original SEC Filing